6 hours PRME Stock Rises 11.8% on Collaboration With Bristol Myers Zacks
Prime Medicine collaborates with Bristol Myers Squibb for the development of T-cell therapies. Shares gain.
Biotech · Bristol · Bristol-Myers Squibb (BMY) · Science
Prime Medicine collaborates with Bristol Myers Squibb for the development of T-cell therapies. Shares gain.
Biotech · Bristol · Bristol-Myers Squibb (BMY) · Science